Mikkael A. Sekeres MD, MS(@MikkaelSekeres) 's Twitter Profileg
Mikkael A. Sekeres MD, MS

@MikkaelSekeres

Chief, Division of Hematology @SylvesterCancer @UMiamiHealth | Clinical scientist, essayist | Author @mitpress | Chair @ASH_hematology Communications | My views

ID:390846254

linkhttp://www.mikkaelsekeres.com calendar_today14-10-2011 16:58:41

4,9K Tweets

9,0K Followers

437 Following

Follow People
Mikkael A. Sekeres MD, MS(@MikkaelSekeres) 's Twitter Profile Photo

I just wrote about Ending Oncology's Toxic Relationship With High Chemotherapy Doses (including sotorasib) for MedPage Today: medpagetoday.com/opinion/second…

account_circle
Mikkael A. Sekeres MD, MS(@MikkaelSekeres) 's Twitter Profile Photo

Cross this off my bucket list -- giving an exert opinion on the health of Ozzie Osbourne! Thanks for the opportunity Fox News and Shiv Sudhakar! foxnews.com/health/ozzy-os…

account_circle
Genevieve Friedman(@genevievefri) 's Twitter Profile Photo

Optimizing [chemotherapy] doses can improve patient outcomes and lower costs. So why aren't we spending the time to determine the right doses for new and old drugs?

Mikkael A. Sekeres MD, MS shared his perspective in MedPage Today

medpagetoday.com/opinion/second…

account_circle
Taylor Lab UM(@TaylorJ_MD) 's Twitter Profile Photo

Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show | Thanks MedPage Today for highlighting our ⁦Sylvester Comprehensive Cancer Center⁩ study! ⁦Justin Watts MD⁩ ⁦Ellen Madarang⁩ ⁦Mikkael A. Sekeres MD, MS⁩ ⁦Sangeetha Venugopal MD,MS medpagetoday.com/hematologyonco…

account_circle
Mikkael A. Sekeres MD, MS(@MikkaelSekeres) 's Twitter Profile Photo

'For my patient, our treatment was no walk in the park - unless that park was set in a bleak, Road Warrior-like post-apocalyptic landscape.' My latest Op-Ed | Ending Oncology's Toxic Relationship With High Chemotherapy Doses medpagetoday.com/opinion/second… Sylvester Comprehensive Cancer Center Genevieve Friedman

account_circle
Blood Cancers Today(@Blood_Cancers) 's Twitter Profile Photo

OncoDaily Naval Daver, M.D. Sanam Loghavi, MD صنم لغوی 🔬🧬 Rami komrokji Mikkael A. Sekeres MD, MS The episode from is now up! The panel addressed unanswered questions such as the value of FLT3 inhibitors, the value of MRD as a prognostic tool, and how to treat patients in the gray zone.

🎧 buff.ly/3JKF6B8

@oncodaily @Daver_Leukemia @sanamloghavi @Ramikomrokji @MikkaelSekeres The #AML episode from #HOPLive24 is now up! The panel addressed unanswered questions such as the value of FLT3 inhibitors, the value of MRD as a prognostic tool, and how to treat patients in the gray zone. 🎧 buff.ly/3JKF6B8
account_circle
Sylvester Comprehensive Cancer Center(@SylvesterCancer) 's Twitter Profile Photo

Dr. Mikkael Sekeres, chief of the Division of shared that his liberal arts brain helps shape how he treats his patients. We recently chatted with Mikkael A. Sekeres MD, MS to learn more about his work and what motivates him. 💬 loom.ly/IILewko

account_circle
PracticeUpdate(@practiceupdate) 's Twitter Profile Photo

Thank you
Mikkael A. Sekeres MD, MS and Sangeetha Venugopal MD,MS for an excellent commentary on Remission Induction vs Immediate Allogeneic for Relapsed or Poorly Responsive . Read for free here: practiceupdate.com/c/164313/48/1

account_circle
Ruben A. Mesa, MD(@mpdrc) 's Twitter Profile Photo

Such an amazing meeting. Deeply excited for the provocative discussions ahead. Huge kudos to the innovative chadi nabhan MD, MBA, FACP who brings his unique experiences, myriads connections, and gift of oratory to advance our field! Naveen Pemmaraju, MD Mikkael A. Sekeres MD, MS Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Sanam Loghavi, MD صنم لغوی 🔬🧬

account_circle